Unlock regulatory insights with Watson. Learn More

Patent Term Extension Application for JEVTANA® (cabazitaxel), U.S. Patent No. 5,847,170

KeyWord(s) CDER, cabazitaxel, JEVTANA®, Patent Term Extension Application , U.S. Patent No. 5,847,170
Docket Item Code E
Center CDER
VIEW ALL (2)Primary Documents